Truqap is used for the treatment of patients with positive (HR+), HER2-negative, advanced or metastatic breast cancers, particularly those with specific genetic alterations. Many patients in India ask whether Truqap is available in Indian Pharmacies. Unfortunately, Truqap is not approved for commercial sale in India. However, Indian Pharma Network (IPN) facilitates its legal import under the Named Patient Program (NPP). This program allows patients with such difficult conditions to access Truqap. IPN provides full support with documentation, regulatory compliance, and safe delivery. Please call / WhatsApp: +91-9310090915.